KRAS and seminoma: Interestingly, although the number of expressed CT genes was significantly higher in the seminoma group with KIT, KRAS and NRAS mutations, expression of 4 genes in stem cell maintenance related pathways were significantly elevated in the nonseminoma group and samples that without driver gene mutations (Figure S2).